Regulation of nuclear factor-kappaB in intestinal epithelial cells in a cell model of inflammation

Fadia R Homaidan1, Iman Chakroun, Marwan E El-Sabban

  • 1Department of Physiology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon. fh01@aub.edu.lb

Mediators of Inflammation
|February 6, 2004
PubMed

Insights

Interleukin-1 (IL-1) activates nuclear factor-kappaB (NF-kappaB) in intestinal cells, influencing inflammation and cell survival. This suggests NF-kappaB is a potential therapeutic target for inflammatory bowel disease.

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Gastroenterology

Background:

  • Interleukin-1 (IL-1) is an inflammatory cytokine found at elevated levels in inflamed mucosa.
  • IL-1 contributes to its effects on intestinal epithelial cells (IEC) by inducing ceramide production.

Purpose of the Study:

  • To investigate the role of nuclear factor-kappaB (NF-kappaB) in IL-1-treated IEC.
  • NF-kappaB is recognized as a pro-inflammatory and anti-apoptotic factor.

Main Methods:

  • Assessed NF-kappaB activity using electrophoretic mobility shift assay.
  • Quantified levels of apoptotic proteins via RNA-protection assay.

Main Results:

  • IL-1 and ceramide significantly activated NF-kappaB levels in IEC.
  • Activation of NF-kappaB correlated with decreased IkappaB-alpha and IkappaB-beta protein levels.
  • IL-1 treatment led to a significant increase in the ratio of anti-apoptotic to pro-apoptotic mRNA in IEC.

Conclusions:

  • NF-kappaB plays a crucial role in regulating pro-inflammatory and/or apoptotic gene expression.
  • NF-kappaB represents an attractive therapeutic target for inflammatory bowel disease (IBD).
Abstract

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...